Philip Ellery

988 total citations
13 papers, 803 citations indexed

About

Philip Ellery is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Philip Ellery has authored 13 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 7 papers in Infectious Diseases and 6 papers in Immunology. Recurrent topics in Philip Ellery's work include HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (5 papers) and Immune Cell Function and Interaction (4 papers). Philip Ellery is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (5 papers) and Immune Cell Function and Interaction (4 papers). Philip Ellery collaborates with scholars based in Australia, United States and South Sudan. Philip Ellery's co-authors include Suzanne M. Crowe, Anthony Jaworowski, Sharon R. Lewin, Secondo Sonza, Paul R. Gorry, Katherine Kedzierska, Johnson Mak, Geza Paukovics, Warner C. Greene and Paul Cameron and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Philip Ellery

13 papers receiving 793 citations

Peers

Philip Ellery
Geza Paukovics Australia
Donald R. Skillman United States
Julie Lewis United Kingdom
Wendy Bakeman United States
Evelyn E. Eisele United States
Eric Lee United States
Gabriela Khoury Australia
Geza Paukovics Australia
Philip Ellery
Citations per year, relative to Philip Ellery Philip Ellery (= 1×) peers Geza Paukovics

Countries citing papers authored by Philip Ellery

Since Specialization
Citations

This map shows the geographic impact of Philip Ellery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Ellery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Ellery more than expected).

Fields of papers citing papers by Philip Ellery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Ellery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Ellery. The network helps show where Philip Ellery may publish in the future.

Co-authorship network of co-authors of Philip Ellery

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Ellery. A scholar is included among the top collaborators of Philip Ellery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Ellery. Philip Ellery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ei, Burtseva, Philip Ellery, Glenn A. Marsh, et al.. (2011). Antiviral activity of arbidol, a broad‐spectrum drug for use against respiratory viruses, varies according to test conditions. Journal of Medical Virology. 84(1). 170–181. 75 indexed citations
2.
Gorry, Paul R., Rebecca L. Dunfee, Megan Mefford, et al.. (2007). Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Δ32 heterozygote. Virology. 362(1). 163–178. 35 indexed citations
3.
Jaworowski, Anthony, Deborah Kamwendo, Philip Ellery, et al.. (2007). CD16+Monocyte Subset Preferentially Harbors HIV‐1 and Is Expanded in Pregnant Malawian Women withPlasmodium falciparumMalaria and HIV‐1 Infection. The Journal of Infectious Diseases. 196(1). 38–42. 80 indexed citations
4.
Ellery, Philip, Emma Tippett, Ya‐Lin Chiu, et al.. (2007). The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo. The Journal of Immunology. 178(10). 6581–6589. 269 indexed citations
5.
Jaworowski, Anthony, Philip Ellery, Claire Ryan, et al.. (2006). Normal CD16 Expression and Phagocytosis ofMycobacterium aviumComplex by Monocytes from a Current Cohort of HIV‐1–Infected Patients. The Journal of Infectious Diseases. 193(5). 693–697. 23 indexed citations
7.
Ellery, Philip & Suzanne M. Crowe. (2005). Phenotypic Characterization of Blood Monocytes From HIV-Infected Individuals. Humana Press eBooks. 304. 343–354. 9 indexed citations
8.
Crowe, Suzanne M., et al.. (2005). Culture of HIV in Monocytes and Macrophages. Current Protocols in Immunology. 70(1). 1 indexed citations
9.
Crowe, Suzanne M., et al.. (2004). Culture of HIV in Monocytes and Macrophages. Current Protocols in Immunology. 62(1). 12.4.1–12.4.13. 11 indexed citations
10.
Kedzierska, Katherine, et al.. (2003). Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy. Journal of Clinical Virology. 26(2). 247–263. 95 indexed citations
11.
Kedzierska, Katherine, Melissa J. Churchill, Philip Ellery, et al.. (2003). Phagocytic Efficiency of Monocytes and Macrophages Obtained From Sydney Blood Bank Cohort Members Infected With an Attenuated Strain of HIV-1. JAIDS Journal of Acquired Immune Deficiency Syndromes. 34(5). 445–453. 11 indexed citations
12.
Kedzierska, Katherine, Philip Ellery, Johnson Mak, et al.. (2002). HIV-1 Down-Modulates γ Signaling Chain of FcγR in Human Macrophages: A Possible Mechanism for Inhibition of Phagocytosis. The Journal of Immunology. 168(6). 2895–2903. 66 indexed citations
13.
Sonza, Secondo, Helen P. Mutimer, Kate O’Brien, et al.. (2002). Selectively ReducedtatmRNA Heralds the Decline in Productive Human Immunodeficiency Virus Type 1 Infection in Monocyte-Derived Macrophages. Journal of Virology. 76(24). 12611–12621. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026